Circular RNA: A promising new star of vaccine

36Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Circular RNAs (circRNAs) are a class of single-stranded RNAs with covalently closed structures. Owing to their not having 3' or 5' ends, circRNAs are highly durable and insusceptible to exonuclease-mediated degradation. Moreover, some circRNAs with certain structures are translatable, making them novel vaccines. Vaccines are efficient tools for immunotherapy, such as for the prevention of infectious diseases and cancer treatment. The immune system is activated during immunotherapy to fight against abnormal allies or invaders. CircRNA vaccines represent a potential new avenue in the vaccine era. Recently, several circRNA vaccines have been synthesized and tested in vitro and in vivo. Our review briefly introduces the current understanding of the biology and function of translatable circRNAs, molecular biology, synthetic methods, delivery of circRNA, and current circRNA vaccines. We also discussed the challenges and future directions in the field by summarizing the developments in circRNA vaccines in the past few years.

Cite

CITATION STYLE

APA

Xie, J., Ye, F., Deng, X., Tang, Y., Liang, J. Y., Huang, X., … Zou, Y. (2023, December 1). Circular RNA: A promising new star of vaccine. Journal of Translational Internal Medicine. Sciendo. https://doi.org/10.2478/jtim-2023-0122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free